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78 The Journal of Thoracic and Cardiobjective: Preoperative renal insufficiency is a predictor of acute renal failure in patients
ndergoing coronary artery revascularization with cardiopulmonary bypass. Off-pump cor-
nary artery bypass grafting has been shown to be less deleterious than on-pump bypass in
atients with normal renal function, but the effect of this technique in patients with non–
ialysis dependent renal insufficiency in a randomized study is unknown.
ethods: From August 2004 through October 2005, 116 consecutive patients with preop-
rative non–dialysis-dependent renal insufficiency (glomerular filtration rate measured using
he Modification of Diet in Renal Disease equation [MDRD GFR] 60 mL · min1 · 1.73
2) undergoing primary coronary artery bypass grafting were randomized to on-pump (n
60) and off-pump (n  56) groups. MDRD GFR and serum creatinine levels were
easured preoperatively and postoperatively at days 1 and 5. The changes in renal function
nd clinical outcomes were compared between the two groups.
esults: Preoperative characteristics were comparable between the two groups. The
epeated-measures analysis of variance was performed on the data that showed wors-
ning of renal function in the on-pump group compared with the off-pump group (serum
reatinine, P .000; glomerular filtration rate, P .000). Further analysis of subgroups
f patients with diabetes alone, hypertension alone, and combined hypertension and
iabetes also showed significant deterioration renal function in the on-pump group
ompared with the off-pump group. In covariate analysis, diabetes has emerged as a
ignificant covariate by serum creatinine criteria while compromised left ventricular
unction has emerged as a significant covariate by glomerular filtration rate criteria.
hese analyses showed that the use of cardiopulmonary bypass is significantly associated
ith adverse renal outcome (P .000). Three patents required hemodialysis in the on-pump
roup and none in the off-pump group. The mean number of grafts per patient was 3.85
.86 and 3.11 0.89 in the on-pump and off-pump groups, respectively (P .001), but the
ndices of completeness of revascularization, 1.00 0.08 for off-pump coronary bypass and
.01  0.08 for on-pump coronary bypass, were similar (P  .60).
onclusions: This study suggests that on-pump as compared with off-pump coronary
rtery bypass grafting is more deleterious to renal function in diabetic patients with
on–dialysis dependent renal insufficiency. MDRD GFR is a more sensitive investiga-
ion than serum creatinine levels to assess renal insufficiency in patients undergoing
oronary bypass.
ardiac operations with cardiopulmonary bypass (CPB) adversely affect renal
function, causing varying degrees of postoperative renal impairment. Post-
operative renal failure remains a serious complication of cardiac surgery,
lthough the incidence of acute renal failure (ARF) necessitating dialysis after
ardiac operations is relatively low (1%-5%).1-4 It is associated with increased
vascular Surgery ● February 2007
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A
CDortality, morbidity, and intensive care unit stay, particu-
arly if there is a requirement for hemodialysis.5-8 The
recise level at which renal dysfunction begins is unknown.
linical impression suggests that even mild or moderate
levation of serum creatinine levels has an adverse effect on
utcome.9 The results of the study by Durmaz and -
eagues10 suggest that even those patients with relativ
ild renal insufficiency remain at risk for a poor outcome.
n patients with creatinine levels higher than 2.5 mg/dL,
here is a strong likelihood of needing postoperative dialysis
esides increased risks of mortality and morbidity. Several
tudies have assessed the risk associated with mild to mod-
rate renal insufficiency in patients undergoing coronary
rtery bypass grafting (CABG).10-12 However, in these stud-
es renal function has been defined according to the levels of
erum creatinine and not by calculated creatinine clearance
r glomerular filtration rate (GFR). Because serum creati-
ine concentration is affected by several factors other than
he filtration of creatinine, calculated creatinine clearance or
FR provides a more accurate estimate of renal functio13
he effect of off-pump CABG (OPCAB) on postoperative
enal impairment has also been controversial. Although it
as been reported that OPCAB may minimize renal injury
n elective patients with normal and impaired preoperative
enal function and in high-risk patients,14-18 other studies
ave failed to show such benefit.19-22 However, there had
een no published data from randomized studies of patients
ith non–dialysis-dependent renal insufficiency undergoing
ABG with or without CPB. In this randomized study, we
valuated the effect of off-pump and on-pump techniques
n renal function assessed by serum creatinine and GFR in
atients with preoperative non–dialysis-dependent renal in-
ufficiency undergoing primary CABG.
atients and Methods
atient Enrollment and Random Assignment
his study was designed to compare the effect of off-pump and
Abbreviations and Acronyms
ARF  acute renal failure
CABG  coronary artery bypass grafting
CPB  cardiopulmonary bypass
GFR  glomerular filtration rate
K/DOQI CKD Kidney Disease Outcomes Quality
Initiative Chronic Kidney Disease
guidelines
LV  left ventricular
LVEF  left ventricular ejection fraction
MDRD Modification of Diet in Renal
Disease
OPCAB  off-pump coronary artery bypass
graftingn-pump techniques on renal function in patients with non– 1
The Journal of Thoracicialysis-dependent renal insufficiency with a GFR of 60 mL ·
in1 · 1.73 m2 or less undergoing primary, elective CABG. In
n effort to minimize variability, all the procedures were per-
ormed by two surgeons (G.M., L.R.S.) experienced in OPCAB
urgery and all patient management was conducted by a single
eam according to strict, unbiased, criteria-driven protocols. After
pproval by the institutional review board and informed consent, a
otal of 120 patients requiring primary CABG at CARE Hospital,
anjara Hills, Hyderabad, India, were enrolled to the study be-
ween August 3, 2004 (first patient) and September 26, 2005
116th patient) and were randomized, 60 patients each, to with-
PB or without-CPB groups by a computer-generated random
umber table. This was done for each patient after the operating
urgeon had documented the intended revascularization to be
erformed, which was based on review of the preoperative coro-
ary angiogram. Random assignment was not stratified by diabetic
tatus, hypertension, or compromised left ventricular (LV) func-
ion. Four of these patients (2 were found to require mitral valve
epair, 1 patient needed emergency CABG because of unstable
ngina, and 1 patient did not report for surgery) dropped out after
andom assignment and were subsequently excluded from the
tudy. All 4 of these patients belonged to the off-pump group.
ence, the total number of intent-to-treat population was 116
atients (on-pump group, n  60; off-pump group, n  56.).
ethods
standard set of perioperative data were collected prospectively
or all patients: age, sex, height, weight, diabetes mellitus, hyper-
ension, peripheral vascular disease, LV ejection fraction (LVEF),
umber of significantly stenosed coronary arteries, prior myocar-
ial infarction, angina class, serum creatinine, and GFR measured
sing the equation of the Modification of Diet in Renal Disease
MDRD) study. All patients in both groups received 600 mg of
-acetylcysteine orally once daily immediately before revascular-
zation and for the first 5 postoperative days. None of the patients
eceived aminoglycosides or nonsteroidal anti-inflammatory
gents perioperatively. Two patients in the on-pump group re-
eived aprotinin 500,000 KIU in the postoperative period because
f excessive mediastinal bleeding due to generalized oozing; the
ther patients in the study did not receive any antifibrinolytics.
ostoperatively, whole blood or packed red blood cells were
ransfused for all patients whose hemoglobin value was less than 9
m/dL.
enal Function
erum creatinine levels and GFRs were measured at the time of
ospitalization and postoperatively on day 1 and day 5. The GFR
as measured with the MDRD equation. Renal insufficiency was
efined according to the guidelines from the National Kidney
oundation.23 The Kidney Disease Outcomes Quality Initiati
hronic Kidney Disease (K/DOQI CKD) guidelines have estab-
ished a 5-stage classification of patients with chronic kidney
isease that is based solely on kidney function. These stages are
efined by a GFR greater than or equal to 90 mL · min1 ·
.73 m2 (stage 1), 60 to 89 mL · min1 · 1.73 m2 (stage 2), 30
o 59 mL · min1 · 1.73 m2 (stage 3), 15 to 29 mL · min1 ·
.73 m2 (stage 4), and less than 15 mL · min1 · 1.73 m2
and Cardiovascular Surgery ● Volume 133, Number 2 379
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A
CDstage 5). Acute renal dysfunction was classified on the basis of
IFLE criteria.*24
stimation of GFR by MDRD Equation
FR was measured by the MDRD formula.23 The variables in-
luded were age, sex, height in centimeters, and weight in kilo-
rams for body surface area calculation, blood urea nitrogen
BUN), serum creatinine (Scr), and serum albumin (Alb). The
ormula used is as follows.
FR (mL · minl · 1.73 m2)
170 (Scr)0.999 (Age)0.716 (BUN)0.070 (Alb)0.318
for male subjects
170 (Scr)0.999 (Age)0.716 (BUN)0.070 (Alb)0.318
 (0.762) for female subjects
(See additional text online.*)
urgical Technique
General. The surgical techniques were followed as described
arlier.25 Surgical access to the heart was through a stan
edian sternotomy in all patients.
(See additional text online.†)
On-pump technique. CPB was instituted with ascending aorta
annulation and 2-stage venous cannulation of the right atrium. A
tandard circuit made of polyvinyl chloride tubing (Lifeline Sys-
ems Pvt Ltd, New Delhi. India), which included a 40-m filter,
nd a Sarns 8000 (Terumo Cardiovascular Systems Corporation,
nn Arbor, Mich) heart-lung machine and a hollow-fiber mem-
rance oxygenator (Affinity NT, Medtronic Inc, Minneapolis,
inn) were used. The extracorporeal circuit was prepared with
000 mL of Ringer’s lactate, 500 mL of hydroxyethyl starch 6%,
.5 g/kg of mannitol, 10 mL of 10% calcium gluconate, 25 mL of
odium bicarbonate IP 7.5% w/v, and 5000 IU of heparin. Non-
ulsatile flow was used. Flow throughout bypass was 2.4 L · m2
min1 and mean perfusion pressure was maintained between
0 and 70 mm Hg by adjusting the doses of nitroglycerine
nd phenylephrine/dobutamine/norepinephrine. The conventional
ABG with CPB was accomplished with every effort made to
inimize the impact of CPB. Intraoperative ultrafiltration was
sed. Systemic temperature was kept between 32°C and 36°C.
yocardial protection was achieved with intermittent ischemic
brillatory arrest or intermittent antegrade hyperkalemic cold
lood cardioplegic arrest based on the operating surgeon’s prefer-
nce of technique of myocardial protection. The proximal anasto-
oses were performed with partial clamping of the ascending
orta, as soon as one distal anastomosis was completed (intermit-
ent ischemic arrest technique) or after completion of all distal
nastomoses (blood cardioplegic technique).
OPCAB technique. The method of exposure and stabilization
o perform the anastomoses consisted of the technique previously
escribed by our group.25 OPCAB was performed with t
edtronic Octopus 3 or 4 (Medtronic, Inc, Minneapolis, Minn)
tabilizing device for target coronary artery stabilization. Target
rteries were accessed either by deep pericardial traction sutures or
y the use of a Medtronic Starfish cardiac positioner (Medtronic,tRIFLE  Risk, Injury, Failure, Loss, ESRD (end-stage renal disease).
80 The Journal of Thoracic and Cardiovascular Surgery ● Febrnc). A mean systemic arterial pressure was maintained around 65
o 70 mm Hg throughout the procedure. An intracoronary shunt
Medtronic, Inc, Grand Rapids, Mich) was used in all vessels
easuring more than 1.25 mm in diameter while constructing the
oronary anastomosis. Visualization of the anastomotic area was
nhanced by using a humidified carbon dioxide blower/mister
Medtronic, Inc, Grand Rapids, Mich) to disperse the blood from
he anastomotic site while constructing the distal anastomoses. For
afety, a CPB machine was kept with the circuit mounted, but not
rimed.
(See additional text online.†)
tatistical Analysis
tatistical analysis was done with SPSS 11.5 for Windows (SPSS,
nc, Chicago, Ill). The proportions of baseline events in the two
reatment groups were compared by the 2 test and the means by
he 2-sample independent t test at P  .05. For the primary
valuation, deterioration in renal function in patients with non–
ialysis-dependent renal insufficiency undergoing primary CABG,
s measured by a rise in serum creatinine/fall in GFR by 20% or
ore of preoperative values, was compared between groups with
nd without CPB. The proportions were compared and at P  .05
onsidered to be statistically significant. Repeated-measures anal-
sis of variance was used to investigate the effect of CPB on renal
unction during surgery. The analysis was performed on log-
ransformed variables and untransformed variables. A P value less
han .05 was considered as significant to test the null hypothesis
hat there is no difference between groups. Number of patients
tudied was considered to be sufficient if a power of 0.8 in
epeated-measures analysis is observed both for main effects and
or interaction. Subgroup analysis was undertaken to study the
PB effect in specific categories of groups. Covariates were in-
roduced in repeated-measures analysis to study the effect of
ovariates at P  .05.
esults
nalysis of Baseline Characteristics
aseline and intraoperative characteristics are shown in
able l. The two groups were similar with respect to
ender, diabetes mellitus, hypertension, smoking, angina
lass, preoperative cerebrovascular accident, and LVEF.
here was no statistically significant difference in preoper-
tive serum creatinine and MDRD GFR levels between the
wo groups (P  .477, P  .774). Mean number of grafts
er patient was 3.85  0.86 and 3.11  0.89 in on-pump
nd off-pump groups, respectively (P .001), but there was
o statistically significant difference in the index of com-
leteness of revascularization: 1.01  0.08 versus 1.00 
.01 (P  .60). There was no conversion of off-pump to
n-pump technique in this study.
orbidity Analysis
atients in the on-pump group showed a higher requirement
or inotropic use (P  .043) and blood transfusion (P 
001). Blood loss was higher in the on-pump group than in
he off-pump group (P  .001). The intubation time for the
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A
CDn-pump group was significantly higher than that for the
ff-pump group: 9.32  6.64 hours versus 5.55  2.28
ours (P  .001). Three patients in the on-pump group
equired hemodialysis compared with none in the off-pump
roup. There was no statistically significant difference in the
ncidence of postoperative cerebrovascular accident (Table 
nalysis of Changes in Serum Creatinine Levels
nd GFR
aving known the effect of a mild to moderate increase in
he preoperative serum creatinine level on outcome, we
nalyzed the changes in serum creatinine levels after CABG
sing univariate and multivariate analyses. In the present
tudy, we found that 35 of 116 (30.%) patients had normal
enal function by serum creatinine criteria (1.29 mg/dL)
nd were in stage 3 of chronic kidney disease by GFR
riteria (GFR  60 mL · min1 · 1.73 m2). In the intent-
o-treat population, the elevation of serum creatinine level at
ostoperative days 1, 5, and 15 in the on-pump group was
tatistically significant compared with the off-pump group
P  .001), as shown in Figure 1, a, and Tables 3A and 3
ncrease in serum creatinine level after CABG by 20% or
ore over the preoperative value was taken as an important
levation and occurred in 39 (62%) of 60 patients in the
n-pump group compared with 17 (30%) of 56 patients in
he off-pump group (P  .000).12 The fall in GFR 
ABLE 1. Baseline characteristics of intent-to-treat
opulation
haracteristics
Without CPB
(n  56)
With CPB
(n  60) P value
ge (y)
Mean 60.0 60.50 .72
SD 8.43 7.87
ale (%) 49 (87.5) 54 (90.0) .67
emale (%) 7 (12.5) 6 (10.0)
V function (LVEF  49%) 42.9 41.7 .20
iabetes (%) 58.9 53.3 .54
ypertension (%) 66.1 76.7 .21
mokers (%) 37.5 43.3 .52
ngina class
II 26.8 20.0
III 58.9 63.3 .68
IV 14.3 16.7
erum creatinine preop
Mean 1.414 1.482 .47
SD 0.5482 0.5482
FR preop
Mean 52.01 51.66 .83
SD 8.607 9.345
value  .05 is statistically not significant. CPB, Cardiopulmonary bypass;
FR, glomerular filtration rate; LV, left ventricular; LVEF, left ventricular
jection fraction; Preop, preoperative; SD, standard deviation.ostoperative days 1 and 5 in the CPB group was statisti- h
The Journal of Thoracically significant compared with the off-pump group (P 
007) (Figure 1, a, and Tables 3A and 3B).
A fall in GFR after CABG by 20% or more of the
reoperative value was taken as an important fall and oc-
urred in 33 (55.0%) of 60 patients in the on-pump group
ompared with 17 (30.4 %) of 56 patients in off-pump group
P  .007).
nalysis of Subset of Patients With Diabetes
wenty-seven (84%) of 32 patients with diabetes in the
n-pump group and 16 (49%) of 33 patients with diabetes in
he off-pump group had an elevation of 20% or more in
erum creatinine over their preoperative values (P  .002)
Tables 3A and E1). Eighteen (56%) of 32 patients 
iabetes in the on-pump group and 12 (36%) of 33 patients
ith diabetes in the off-pump group had a 20% or greater
all in GFR over their preoperative values, which did not
each statistical significance (P  .108) (Tables 3A and E1
his 20% fall in GFR may not have reached conventional
tatistical significance, but it is still a clinically important
ifference and may reflect that this study was underpowered
o detect statistically significant differences in the fall of
FR of 20% with both techniques. However, in means and
epeated-measures analysis, on-pump patients showed sig-
ificant deterioration in renal function by both serum cre-
tinine and GFR criteria (P  .000) (Table E1).
nalysis of Subset of Patients With Hypertension
hirty (63%) of 46 patients who were hypertensive in the
n-pump group and 13 (35%) of 37 patients who were hyper-
ensive in the off-pump group showed a 20% elevation or
reater of serum creatinine over their preoperative values (P
011) (Tables 3A and E2).
Twenty-six (56.5%) of 46 patients who were hypertensive
n the on-pump group and 12 (32%) of 37 patients who were
ABLE 2. Postoperative clinical outcomes
ariable Without CPB With CPB P value
notropic requirement 26 (46) 40 (67) .043
lood transfusion
(units/patient)
0.77 0.85 1.88 0.71 .001
hest tube drainage (mL) 360 109 542 161 .001
ostop dialysis 0 3 —
eaths 0 3 —
VA 0 1 —
ean number of grafts/patient 3.11 0.89 3.85 0.86 .001
OCR 1.00 0.08 1.01 0.08 .60
ntubation time (h) 5.55 2.28 9.32 6.64 .001
PB, Cardiopulmonary bypass; CVA, cerebrovascular accident; IOCR, in-
ex of completeness of revascularization.ypertensive in the off-pump group showed a 20% fall or
and Cardiovascular Surgery ● Volume 133, Number 2 381
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A
CDreater in GFR over their preoperative value (P  .029)
Tables 3A and E2).
V Dysfunction
he rise in serum creatinine in patients with fair or poor LV
unction (LVEF 49%) was greater in the CPB group than in
he OPCAB group, but the rise did not reach statistical signif-
cance (P  .100) and the fall in GFR was statistically signif-
cant in the CPB group compared with the OPCAB group (P
0.32) (Table 3A).
Means and repeated-measures analysis of results of preop-
rative and postoperative levels of serum creatinine and GFR
igure 1. A, Serum creatinine levels preoperatively (A) and on
ostoperative days 1 (B), 5 (C), and 15 (D) in patients undergoing
ABG with CPB and without CPB (P < .001). B, MDRD GFR
reoperatively (A) and on postoperative days 1 (B) and 5 (C) in
atients undergoing CABG with or without CPB (P < .007).howed elevation of serum creatinine and fall of GFR values in y
82 The Journal of Thoracic and Cardiovascular Surgery ● Febroth groups (with CPB and without CPB). The inspection of
eans and geometric means of the overall intent-to-treat pop-
lation showed that the on-pump group had higher postoper-
tive values than the off-pump group at all points of time,
lthough the baseline values were similar (serum creatinine, P
 .000; GFR, P  .000; Table 3B).The analysis was also d
or the subsets of patients with diabetes and hypertension,
hich showed statistically significant deterioration in renal
unction by both serum creatinine and GFR criteria in the
n-pump group (diabetes, P  .000; hypertension, P .000;
ables E1 and E2).
The direct effects of inotropic use, blood transfusion, intu-
ation time, and presence of diabetes mellitus, hypertension,
nd compromised LV function (LVEF  49%) on renal out-
omes as measured by serum creatinine and MDRD GFR are
tudied, introducing all the above variables as covariates in the
epeated-measures analysis. The analysis shows that diabetes
ellitus has emerged as a significant covariate by serum cre-
tinine criteria and compromised LV function has emerged as
 significant covariate by GFR criteria (Tables 4A and 4B
ther covariables (hypertension, blood transfusion, inotropic
se, and intubation time) were found to be statistically not
ignificant (P  .05). In both the analyses, use of CPB is
ignificantly associated with adverse renal outcome (P .000).
he observed power is sufficiently high and hence the sample
s sufficient to draw valid conclusions.
nalysis of Postoperative Changes in Serum
reatinine and GFR in Subset of Patients With
reoperative Normal Serum Creatinine (<1.29 mg/dL)
nd Decreased GFR (<60 mL · min1 · 1.73 m2).
his subgroup of patients was analyzed for changes in post-
perative renal function. There was significant rise in serum
reatinine levels in the CPB group compared with the off-
ump group (P  .002), but there was no statistically signif-
cant further fall in GFR between the two groups (P  .108).
ortality Analysis
hree deaths occurred in the on-pump group and no deaths
n the off-pump group (P  .09). The 3 patients who died
ad preoperative serum creatinine values of 0.9, 2.1, and 1.7
g/dL and GFR values of 48.12, 31.59, and 46.52 mL ·
in1 · 1.73 m2, respectively. There was a fall in GFR on
he first postoperative day in all 3 patients, and GFR values
ere 39.18, 25.15, and 25.16 mL · min1 · 1.73 m2,
espectively. There was a rise in serum creatinine on the first
ostoperative day and the values were 1.6, 2.6, and 2.3
g/dL respectively. Two patients who had postoperative
RF had fair LV function and 1 patient had good LV
unction.
All patients who had ARF postoperatively were aged 62ears and above.
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A
CDOnly 1 patient was diabetic and none was hypertensive
mong the deceased. The cause of death in all 3 patients was
ostoperative ARF.
iscussion
ostoperative ARF in patients undergoing CABG has been
ssociated with high morbidity and mortality.1-4 The bench-
ABLE 3A. Deterioration in renal function as measured
reoperative values
opulation Variable
TT Serum creatinine
GFR
iabetes Serum creatinine
GFR
ypertension Serum creatinine
GFR
iabetes  hypertension Serum creatinine
GFR
air or poor LV function Serum creatinine
GFR
atients who did not require inotropes Serum creatinine
GFR
value  .05 is statistically significant. CPB, Cardiopulmonary bypass; G
ABLE 3B. Means and repeated-measures analysis of res
PB N Mean SD Ge
. creatinine preop
Without CBP 56 1.414 .4342
With CBP 60 1.482 .5482
. creatinine POD 1
Without CBP 56 1.623 .4411
With CBP 60 1.922 .7529
. creatinine POD 5
Without CBP 56 1.700 .7234
With CBP 60 2.001 .9082
. creatinine POD 15
Without CBP 56 1.425 .4140
With CBP 60 1.582 .5410
DRD GFR preop
Without CBP 56 52.014 8.6072
With CBP 60 51.662 9.3451
DRD GFR POD 1
Without CBP 56 49.6804 14.73726
With CBP 60 40.6973 14.62146
DRD GFR POD 5
Without CBP 56 53.9632 10.74941
With CBP 60 44.6200 12.47290
he log-transformed serum creatinine/GFR values were subjected to stati
onary bypass; MDRD GFR, modification of diet in renal diseases equation
f time during postoperative period; CPB  time, interaction of the procedure
The Journal of Thoracicark study conducted by Chertow and colleagues5 reported
mortality of 63% at 30 days for those patients requiring
emodialysis compared with 4.3% for those without renal
ysfunction. A more recent work by Mangano and associ-
tes7 identified similar mortality rates among patients w
ostoperative renal failure. Baseline renal impairment has
een consistently identified as a major predictor for postop-
ise in serum creatinine/fall in GFR by 20% or more of
Without CPB With CPB
P valueN % N %
56 30.4 60 61.7 .001
56 30.4 60 55.0 .007
33 48.5 32 84.4 .002
33 36.4 32 56.3 .108
37 35.1 46 63.0 .011
37 32.4 46 56.5 .029
23 52.2 27 85.2 .011
23 43.5 27 59.3 .266
24 29.2 25 52.0 .100
24 37.5 25 68.0 .032
30 23.3 20 75.0 .001
30 63.3 20 40.0 .105
omerular filtration rate; ITT, intent-to-treat; LV, left ventricular.
of preoperative and postoperative values
ic mean
ANOVA results
Significant effect Power F P
66
Time
CPB time
59.52
3.889
.000 1.000
.004 0.833
16
79
33
95
61
87
11
01
Time
CPB time
35.707
13.808
.000 1.000
.000 0.998
02
888
746
838
257
analysis using repeated-measures analysis of variance. CPB, Cardiopul-
erular filtration rate; POD, postoperative day; Time, changes with durationby rults
ometr
1.3
1.4
1.5
1.8
1.5
1.8
1.3
1.5
51.1
50.5
47.0
38.1
52.8
42.9
stical
glomwith or without CPB  time; SD, standard deviation.
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CDrative renal failure. The majority of factors associated with
ncreased risk of developing ARF are patient related and
eyond the clinician’s control, the exception being use or
onuse of CPB.
Although serum creatinine alone is the most widely used
ssay to measure the presence and progression of chronic
idney disease, equations based on serum creatinine level,
ge, sex, and other variables are more sensitive at predicting
hanges in renal function.26 The Cockcroft-Gault equation
as developed to estimate creatinine clearance27 but has
een used to estimate GFR with relatively good precisio28
Recently, several equations have been developed using
he MDRD study to estimate GFR directly.29 Serum creat-
nine level is not as accurate as GFR to assess renal func-
ion.13 We also found in our study that, preoperatively, 
f patients with a normal level of serum creatinine (1.29
g/dL) were in stage 3 of chronic kidney disease (the
/DOQI CKD 5-stage classification).23
With the resurgence of interest in CABG without the use
f CPB, there were a few observational comparative studies
ublished on CABG with or without using CPB in patients
ith preoperative non–dialysis-dependent renal insufficiency.
ll these studies showed that OPCAB reduces in-hospital
orbidity and likelihood of ARF in patients with preoperative
on– dialysis-dependent renal insufficiency.14-18 Yet other
onrandomized studies failed to show the renoprotective
ffect of the off-pump technique in non–dialysis-dependent
enal insufficiency where serum creatinine levels were used
o define renal insufficiency.19-22
CPB represents a specific risk factor during cardiac sur-
ABLE 4A. Multivariate tests for changes in serum creatin
ffect Value F
actor 1
Pillai’s trace .074 2.868b
actor 1 * diabetes
Pillai’s trace .308 15.896b
actor 1 * hypertension
Pillai’s trace .020 .725b
actor 1 * intubation time
Pillai’s trace .056 2.118b
actor 1 * blood transfusion
Pillai’s trace .024 .895b
actor 1 * compromised LV function
Pillai’s trace .035 1.302b
actor 1* inotropic use
Pillai’s trace .005 0.189b
actor 1 * CPB
Pillai’s trace .174 7.516b
Denotes interaction.
Computed using alpha  .05; bexact statistic. Model design: Intercept 
ompromised; left ventricular (LV) function  inotropic use  cardiopulm
reoperative and postoperative days 1, 5, and 15; df, degrees of freedom.ery. The injurious effect of CPB on renal function is l
84 The Journal of Thoracic and Cardiovascular Surgery ● Febraused by several mechanisms including nonpulsatile per-
usion, renal hypoperfusion, hypothermia, and increased
evels of circulating catecholamines, cytokines, and free
emoglobin.30,31 CPB induces transient renal injury in -
ients undergoing cardiac surgical procedures as evidenced
y decreased tubular function and increased levels of mark-
rs of glomerular and tubular damage. Free plasma hemo-
lobin, elastase and endothelin, and free radicals including
uperoxide, hydrogen peroxide, and hydroxyl radicals may
e generated during CPB and may determine injury in the
enal brush-border membrane.32 The effect, in turn, c
roduce renal dysfunction, especially in the presence of
dditional risk factors like pre-existing renal dysfunction,
iabetes, and hypertension.33 Changes in these parameter
ere essentially confined to the intraoperative and immedi-
te postoperative periods and returned to baseline levels
ithin 2 days.4 It was also documented by Karkouti 
olleagues34 that there was an independent association -
ween the degree of hemodilution during CPB and periop-
rative ARF necessitating dialysis support.
The off-pump technique for coronary revascularization
as popularized in the early 1990s and led to investigation
s to whether the avoidance of CPB altogether would min-
mize postoperative renal injury and/or insufficiency. Use of
eating heart techniques means maintenance of pulsatile
ow and no exposure to the extracorporeal circuit, with an
nticipated reduction in the inflammatory cytokine re-
ponse, normothermia, and a decreased requirement for
asoconstrictor administration to maintain target mean ar-
erial pressure.20 However, some of the previously pu-
levels
Hypothesis df Error df Sig. Observed powera
3 107 .040 .672
3 107 .000 1.000
3 107 .540 .200
3 107 .102 .527
3 107 .447 .240
3 107 .278 .339
3 106 .904 0.089
3 107 .000 .984
etes mellitus  hypertension  intubation time  blood transfusion 
bypass (CPB) within subjects design: Factor 1: Serum creatinine levels:ine
diab
onaryished retrospective analyses, which assessed changes in
uary 2007
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A
CDenal function using serum creatinine levels, have failed to
emonstrate a significant renoprotective effect of the off-
ump technique.21,22 The study by Stallwood and c-
eagues8 showed that CPB is associated with a significa
ncreased risk of ARF after isolated CABG.
Although early reports of subtle reduction in renal insult
nd promising findings from nonrandomized outcome stud-
es hinted at benefit, many nonrandomized studies including
 meta-analysis failed to confirm the advantage.35 However,
any such studies ignored the question most important to
he clinicians: does off-pump surgery confer benefit to the
atient with non–dialysis dependent renal insufficiency?
To the best of our knowledge, there has been no random-
zed study published comparing the effect of off-pump and
n-pump CABG in patients with non–dialysis dependent re-
al insufficiency defined by GFR as well as serum
reatinine.
In our study, 30% of patients with preoperative normal
erum creatinine levels (1.29 mg/dL) were found to be in
tage 3 of chronic kidney disease by GFR criteria (GFR 
0 mL · min1 · 1.73 m2). It indicates that GFR is a more
ensitive indicator for evaluating renal function preopera-
ively than serum creatinine estimation. Although Wijey-
undera and colleagues36 proposed a simple calculated cr-
tinine clearance in preoperative assessment, which might
mprove identification of patients at risk of needing postop-
rative renal replacement therapy, the estimation of GFR is
ore sensitive in predicting requirement of renal replace-
ent therapy in patients with non–dialysis dependent renal
ABLE 4B. Multivariate tests for changes in glomerular fil
ffect Value F
actor 1
Pillai’s trace .087 5.171b
actor 1 * diabetes
Pillai’s trace .041 2.301b
actor 1 * hypertension
Pillai’s trace .005 .267b
actor 1 * intubation time
Pillai’s trace .001 .063b
actor 1 * blood transfusion
Pillai’s trace .025 1.394b
actor 1 * compromised LV function
Pillai’s trace .056 3.207b
actor 1 * inotropic usage
Pillai’s trace .026 1.417b
actor 1 * CPB
Pillai’s trace .191 12.712b
Denotes interaction.
Computed using alpha  .05; bexact statistic. Model design: Intercept 
ompromised left ventricular (LV) function  inotropic usage  cardiopulm
reoperative and postoperative days 1 and 5; df, degrees of freedom.nsufficiency. Further, this study showed a significant rise in c
The Journal of Thoracicerum creatinine levels at postoperative day 1 and day 5 in
he CPB group compared with the OPCAB group (P 
001) and a statistically significant fall in GFR in the CPB
roup compared with the OPCAB group (P  .007).
It is also observed that significantly more patients with
iabetes showed further elevation of serum creatinine in
he postoperative period in the on-pump group than in the
ff-pump group (P  .002). These findings suggest that the
ff-pump technique is more renoprotective in patients with
on–dialysis dependent renal insufficiency.
More hypertensive patients undergoing CABG showed
eterioration in renal function (rise in serum creatinine and
all in GFR) in the postoperative period in the on-pump
roup than in the off-pump group (serum creatinine, P 
011; GFR, P  .029).
In patients with compromised LV function, the fall in
FR was also significant in the CBP group compared with
he OPCAB group (P  .032) whereas the rise in serum
reatinine levels was not significant (P  .10).
In our study, repeated-measures analysis of variance and
ovariate analysis showed the use of CPB is significantly
ssociated with adverse renal outcome. In addition, the
ffects of inotropic use, blood transfusion, intubation time,
nd the presence of diabetes mellitus, hypertension, and
ompromised LV function on renal outcomes as measured
y serum creatinine and MDRD GFR are studied, introduc-
ng all these variables as covariates in the repeated-mea-
ures analysis. Diabetes mellitus has emerged as a signifi-
ant covariate (by serum creatinine levels) and
on rate
Hypothesis df Error df Sig. Observed powera
2 108 .007 .818
2 108 .105 .458
2 108 .767 .091
2 108 .939 .059
2 108 .253 .294
2 108 .044 .602
2 107 .247 .298
2 108 .000 .996
etes mellitus  hypertension  intubation time  blood transfusion 
y bypass (CPB) within subjects design: Factor 1: Glomerular filtration rate:trati
diab
onarompromised LV function as a significant covariate (by
and Cardiovascular Surgery ● Volume 133, Number 2 385
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A
CDFR criteria), and all other covariates were not statistically
ignificant.
A couple of randomized trials of evaluating N-acetylcys-
eine to prevent renal dysfunction in high-risk patients un-
ergoing CABG have shown that N-acetylcysteine was in-
ffective in preventing renal dysfunction.37 However, we
hose to use N-acetylcysteine for both groups of our patients
ith non–dialysis dependent renal insufficiency because, in
enal diseases, N-acetylcysteine was initially tested in an
xperimental model of ischemic ARF, resulting in protec-
ive effects on renal function and structure.38
A systematic review and meta-analysis of randomized
linical trials conducted on the effect of aprotinin on clinical
utcomes in CABG revealed the concern that aprotinin
herapy is associated with increased mortality, myocardial
nfarction, or renal failure risk, but this concern is not
upported by the data published. In our study, only 2 pa-
ients in the on-pump group received aprotinin who had
xcessive mediastinal bleeding due to generalized oozing,
espite adequate heparin neutralization, and they did not
how important (20%) deterioration in renal function ei-
her by serum creatinine or GFR criteria.39
This randomized study confirmed the renoprotective ef-
ect of OPCAB of the previously published observational
tudies that used serum creatinine level alone to assess
reoperative renal function.8,14-18 Furthermore, we found
hat patients who have diabetes, hypertension, and compro-
ised LV function fared worse with the on-pump tech-
ique. This study also showed that GFR is a more sensitive
nvestigation to assess renal function in the preoperative
eriod. By evaluating renal function preoperatively using
FR in patients undergoing CABG, one would be able to
etect compromised renal function even in the presence of
ormal serum creatinine levels. This knowledge enables the
perating team to take necessary measures to prevent fur-
her deterioration in renal function by preferentially using
he off-pump technique for surgical revascularization.
imitations of the Study
ur study is a single-center study and is limited by the
umber of patients enrolled in the study. It is also limited by
ack of data on the progression of renal impairment during
he follow-up period.
onclusions
PCAB is more renoprotective for patients with non–dial-
sis-dependent renal insufficiency. The renoprotective ef-
ect is more pronounced in patients with diabetes, hyper-
ension, and compromised LV function. We suggest that all
atients undergoing CABG may need preoperative assess-
ent of renal function by GFR in addition to serum creat-nine levels to stratify the risk for postoperative ARF and to
86 The Journal of Thoracic and Cardiovascular Surgery ● Febrptimize measures for renal preservation during surgical
yocardial revascularization.
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iscussion
r John D. Puskas (Atlanta, Ga). My congratulations to you and
our colleagues from Hyderabad for enrolling 116 patients in 16
onths in a randomized surgical trial. That may be a world record
or a single center.
Your study has again demonstrated, as others have, that OPCAB
s associated with a significant decrease in inotrope dependence,
ransfusion, chest tube drainage, and ventilation time. You have also
ound a trend toward a decrease in death and postoperative hemodi-
lysis, but your primary end point was to focus on the increase in
erum creatinine and decline in GFR after CPB, and you demon-
trated a benefit for OPCAB that was greatest in diabetic patients and
n hypertensive patients. I have several questions for you.
First, how well did you control the mean CPB perfusion pres-
ures during the on-pump cases, and how did that compare with the
ean arterial pressures during off-pump surgical procedures? In
ther words, is it a matter of perfusion of the body during these two
perations or is it something else related to the pump that would
xplain your differences?
Dr Sajja. Thank you, Dr Puskas, for your comments and ques-
ions. In the on-pump group, we maintained the systemic mean
rterial pressure at around 65 to 70 mm Hg, while in the off-pump
roup, most of the time the mean pressure was about 70 to 75 mm Hg.
sually, when we revascularize the anterior vessels, the mean pres-
ure is much higher than what we maintain on the pump.
Dr Puskas. You found after surgery that there was an increased
ependence on inotropes in the on-pump group relative to the
ff-pump group. Were you able to examine those subsets of
atients who required inotropes in both groups and compare renal
utcomes between these subgroups? In other words, is it a matter
f inotrope dependence after the pump run that explains the
ifference in renal outcomes or is it something else?
Dr Sajja. We have analyzed the inotropic requirements be-
ween the two groups and found a significant number of patients
equire inotropes in the on-pump group, but we have not analyzed
hether inotropic requirement is an independent predictor of renal
ailure or not. The myocardial protection that occurred during
ff-pump is better than on-pump CABG.
Dr Richard J. Shemin (Boston, Mass). I think this paper is
lso important in that you emphasize that 30% of patients with
ormal serum creatinine values actually have renal disease. But my
eal question is, in the on-pump group compared with the off-pump
roup, how many conversions did you have from off-pump to
n-pump and did you analyze the data on an intent-to-treat basis if
ou did have such conversions?
Dr Sajja. Fortunately, none of the patients in this study in the
ff-pump group needed conversion to CPB. We have been doing the
ff-pump surgery since 1996 and the technique has been standardized.
Dr Ralph J. Damiano (St Louis, Mo).I would like to echo the
ongratulations from the other discussants, Dr Sajja, on a well-
erformed randomized study. My question is really a follow-up on
r Puskas’s question. Did you look at the use of nephrotoxic drugs
etween each group? In particular, was aprotinin used more often
n the on-pump group? How about other drugs like alpha agonists,
and Cardiovascular Surgery ● Volume 133, Number 2 387
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CDhich clearly could have an adverse effect on renal function?
ould this potentially explain the difference as opposed to the use
f the pump itself?
Finally, could you share with us whether the advantages of the
ff-pump technique also extend to the dialysis-dependent group in
our experience?
Dr Sajja. Thank you for your questions. Regarding the use of
ephrotoxic drugs, we have avoided using aminoglycosides and
ther nephrotoxic drugs in all of these patients, whether they are88 The Journal of Thoracic and Cardiovascular Surgery ● Febriven N-acetylcysteine preoperatively and for 5 days postopera-
ively.
We do not have much experience with dialysis-dependent
atients undergoing CABG, only a couple of cases; therefore, I
annot comment on the advantages of the off-pump technique in
his subset of patients.
Dr Damiano. Do you use aprotinin in the on-pump group?
Dr Sajja. Only 2 patients received aprotinin in the on-pump
roup and none in the off-pump group. The use of aprotinin is not
reated on-pump or off-pump, but in all these patients we have common in our institution.uary 2007
E-Anesthesia Technique*
E-The anesthetic technique was standardized for all patients. This
consisted of intravenous anesthesia with propofol infusion at 3 mg
· kg1 · h1. The neuromuscular blockade was achieved by 0.1 to
0.15 mg/kg vecuronium bromide and lungs ventilated to normo-
capnea with medical air and oxygen (45%-50%) without positive
end-expiratory pressure. In the on-pump group, phenylephrine or
nitroglycerin was used to maintain a systemic mean pressure of 60
to 70 mm Hg. In the off-pump group, a mean systemic arterial
pressure of 65 mm Hg or above was maintained with increments of
dobutamine or norepinephrine or volume as directed by the hemo-
dynamic condition.
E-Heparin and Protamine Management*
E-In the on-pump group, heparin was given at a dose of 300 IU/kg
to achieve activated clotting times of 450 seconds or above before
institution of CPB. The activated clotting time was monitored
during the bypass period (every 30 minutes) and additional heparin
was administered if required. In the off-pump group, 100 IU/kg of
heparin was administered before the start of the first distal anas-
tomosis to achieve an activated clotting time of 250 to 350 sec-
onds. On completion of all anastomoses, protamine was given to
reverse the effect of heparin and return the activated clotting time
to preoperative levels.
E-Surgical Technique†
E-All incision and closure techniques were the same in both
groups. No cell salvage device was used during these procedures.
The distal anastomosis for the left internal thoracic artery graft was
constructed with 8-0 polypropylene continuous suture, and for the
saphenous vein and radial artery grafts 7-0 polypropylene suture
was used. All the proximal anastomoses of radial artery grafts were
constructed with 7-0 polypropylene suture and those of the saphe-
nous vein grafts were constructed with 6-0 polypropylene suture.
E-Definitions†
E-Patients were defined as having diabetes mellitus if they were
taking insulin or oral hypoglycemic agents, and as having hyper-
tension if they were taking antihypertensive medication. A coro-
nary artery was defined as significantly obstructed if the luminal
diameter was narrowed at least 50% as assessed visually by the
cardiologist performing the coronary angiography. LVEF was
assessed by using 2-dimensional echocardiography, and LV func-
tion was categorized as normal, fair, or poor according to an LVEF
of 50% or more, 40% to 49%, or 39% or less, respectively.
Postoperative blood loss was defined as total chest tube drainage,
and neurologic complications included permanent and transient
stroke. Pulmonary complications included chest infection, ventilation
failure, reintubation, and tracheostomy.
E-Outcome Data†
E-Intraoperative data and postoperative data were entered prospec-
tively into our database. In-hospital mortality was defined as any
death occurring within 30 days of operation. Heart rate, rhythm,
and ST-segment changes were continuously displayed in a monitor
inclusive of an automated detector of segment elevations and
arrhythmias during the first 48 hours postoperatively (Agilent V
24C; Hewlett-Packard, Boebinger, Germany). Perioperative myo-
cardial infarction, ST-segment changes, pacing, arrhythmias, and
inotropic requirement were recorded. Renal complications includ-
ing further rise in serum creatinine level and fall in GFR and ARF
necessitating hemodialysis were recorded.
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TABLE E1. Means and repeated-measures analysis of results of preoperative and postoperative values in the subset of
patients with diabetes
CPB N Mean SD Geometric mean
ANOVA results
Significant effect power F P
S. creatinine preop
Without CBP 33 1.421 .5128 1.355
Time
CBP time
111.2
9.07
.000 1.000
.000 0.997
With CBP 32 1.497 .5986 1.427
S. creatinine POD1
Without CBP 33 1.709 .4946 1.658
With CBP 32 2.078 .8754 1.981
S. creatinine POD 5
Without CBP 33 1.785 .8228 1.658
With CBP 32 2.027 1.0750 1.862
S. creatinine POD 15
Without CBP 33 1.482 .4908 1.431
With CBP 32 1.531 .5025 1.470
MDRD GFR preop
Without CBP 33 50.324 9.2658 49.246
Time
CBP time
14.08
11.47
.000 0.998
.000 0.990
With CBP 32 51.684 9.8444 50.441
MDRD GFR POD 1
Without CBP 33 47.6788 16.76566 44.3771
With CBP 32 41.7712 17.29179 38.5223
MDRD GFR POD 5
Without CBP 33 52.3109 11.30933 51.1333
With CBP 32 46.4357 13.81849 44.6585
The log-transformed serum creatinine/GFR values were subjected to statistical analysis using repeated-measures analysis of variance. CPB, Cardiopul-
monary bypass; MDRD GFR, Modification of Diet in Renal Disease equation glomerular filtration rate; POD, postoperative day; time, changes with duration
of time during postoperative period; CPB  time, interaction of the procedure with or without CPB  time; SD, standard deviation.
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TABLE E2. Means and repeated measures analysis of results of preoperative and postoperative values in subset of patients
with hypertension
CPB N Mean SD Geometric mean
ANOVA results
Significant effect power F P
S. creatinine preop
Without CBP 37 1.459 .5036 1.399
Time
CBP time
52.59
4.95
.000 1.000
.003 0.899
With CBP 46 1.522 .5970 1.448
S. creatinine POD 1
Without CBP 37 1.670 .5206 1.611
With CBP 46 1.980 .8248 1.880
S. creatinine POD 5
Without CBP 37 1.781 .8498 1.645
With CBP 46 2.014 .9543 1.873
S. creatinine POD 15
Without CBP 37 1.478 .4911 1.426
With CBP 46 1.533 .4341 1.485
MDRD GFR preop
Without CBP 37 50.765 9.8232 49.564
Time
CBP time
20.14
8.11
.000 0.998
.000 0.990With CBP 46 51.632 9.8995 50.305
MDRD GFR POD 1
Without CBP 37 49.5938 17.37142 46.0118
With CBP 46 40.2039 15.33329 37.4183
MDRD GFR POD 5
Without CBP 37 53.5505 12.50092 52.1110
With CBP 46 44.7218 12.08288 43.1542
The log-transformed serum creatinine/GFR values were subjected to statistical analysis using repeated-measures analysis of variance. CPB, Cardiopul-
monary bypass; MDRD GFR, Modification of Diet in Renal Disease equation glomerular filtration rate; POD, postoperative day; time, changes with duration
of time during postoperative period; CPB  time, interaction of the procedure with or without CPB  time; SD, standard deviation.
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